Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData Read more
Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData Read more
PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis: GlobalData Read more
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more
KDCA, SK bioscience launch support programme to shield South Korea against future pandemic influenza threats Read more
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD: GlobalData Read more